Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by THOMAS KOSTEN and COREEN DOMINGO.
THOMAS KOSTEN
Connection Strength
9.731
COREEN DOMINGO
  1. Proceedings of the 35th Annual Meeting & Scientific Symposium. Am J Addict. 2025 Mar; 34(2):119.
    View in: PubMed
    Score: 0.974
  2. Highlights and insights from the 34th AAAP Annual Meeting and Scientific Symposium. Am J Addict. 2024 Mar; 33(2):115-116.
    View in: PubMed
    Score: 0.908
  3. 2021 Year in review: Adjusting to a post-COVID "Normal". Am J Addict. 2022 07; 31(4):268-269.
    View in: PubMed
    Score: 0.809
  4. 2020 Year in Review: A Look Back With an Eye Toward the Future. Am J Addict. 2021 05; 30(3):217-218.
    View in: PubMed
    Score: 0.746
  5. Evolution of the Journal of the American Academy of Addiction Psychiatry: The American Journal on Addictions. Am J Addict. 2020 09; 29(5):375-377.
    View in: PubMed
    Score: 0.713
  6. Editorial: The Year in Review Amidst the COVID-19 Crisis. Am J Addict. 2020 05; 29(3):172-173.
    View in: PubMed
    Score: 0.696
  7. Editorial: Continuing the Partnership of AJA With the AAAP. Am J Addict. 2019 05; 28(3):148-149.
    View in: PubMed
    Score: 0.650
  8. Editorial: A new partnership with the AAAP newsletter. Am J Addict. 2018 06; 27(4):257-258.
    View in: PubMed
    Score: 0.610
  9. Commentary. Am J Addict. 2018 Apr; 27(3):157.
    View in: PubMed
    Score: 0.603
  10. Editorial. Am J Addict. 2018 Jan; 27(1):5-6.
    View in: PubMed
    Score: 0.593
  11. Editorial. Am J Addict. 2016 06; 25(4):252-3.
    View in: PubMed
    Score: 0.531
  12. Can you vaccinate against substance abuse? Expert Opin Biol Ther. 2013 Aug; 13(8):1093-7.
    View in: PubMed
    Score: 0.428
  13. Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines. Vaccines (Basel). 2025 Feb 13; 13(2).
    View in: PubMed
    Score: 0.243
  14. Anti-Cocaine IgA Rather Than IgG Mediates Vaccine Protection from Cocaine Use. Pharmaceutics. 2022 Nov 03; 14(11).
    View in: PubMed
    Score: 0.207
  15. A Clinical Trial of Entolimod a TLR-5 Adjuvant for Vaccines Using Diphtheria or Tetanus as Carrier Proteins. Vaccines (Basel). 2022 Sep 22; 10(10).
    View in: PubMed
    Score: 0.206
  16. Pharmacogenetics of Dopamine ?-Hydroxylase in cocaine dependence therapy with doxazosin. Addict Biol. 2019 05; 24(3):531-538.
    View in: PubMed
    Score: 0.150
  17. Smoking reduction and quality of life in chronic patients with schizophrenia in a Chinese population--A pilot study. Am J Addict. 2016 Mar; 25(2):86-90.
    View in: PubMed
    Score: 0.130
  18. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opin Emerg Drugs. 2015 Mar; 20(1):15-29.
    View in: PubMed
    Score: 0.120
  19. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
    View in: PubMed
    Score: 0.115
  20. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb; 77(2):368-74.
    View in: PubMed
    Score: 0.113
  21. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett. 2013 Apr 29; 541:29-33.
    View in: PubMed
    Score: 0.106
  22. Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant. Am J Drug Alcohol Abuse. 2020; 46(2):184-193.
    View in: PubMed
    Score: 0.043
  23. Buprenorphine for the treatment of posttraumatic stress disorder. Am J Addict. 2019 02; 28(2):86-91.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.